News for AC Immune Stock (ACIU)

AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates

Zacks Investment Research • 08/06/24

AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024

GlobeNewsWire • 07/31/24

AC Immune: Takeda Partnership Brings Funds To Drive Pipeline Forward

Seeking Alpha • 07/26/24

AC Immune's ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer's Disease

GlobeNewsWire • 07/25/24

AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024

GlobeNewsWire • 05/28/24

Alzheimer's vaccine licensing deal boosts AC Immune

Market Watch • 05/13/24

Why Is AC Immune (ACIU) Stock Up 45% Today?

InvestorPlace • 05/13/24

AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewsWire • 05/13/24

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease

Business Wire • 05/13/24

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update

GlobeNewsWire • 03/14/24

AC Immune Announces Upcoming Presentations at AD/PD™ 2024

GlobeNewsWire • 02/22/24

Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround

Zacks Investment Research • 01/30/24

AC Immune to Regain Global Rights to Crenezumab and Semorinemab

GlobeNewsWire • 01/22/24

AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?

Zacks Investment Research • 01/18/24

5 Small-Cap Stocks to Play the January Effect

Zacks Investment Research • 01/08/24

AC Immune (ACIU) Upgraded to Buy: Here's Why

Zacks Investment Research • 01/03/24

AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases

GlobeNewsWire • 01/03/24

AC Immune: Initial AD Findings Bring About Two Upcoming Catalysts

Seeking Alpha • 12/18/23

AC Immune Announces Pricing of Underwritten Offering of Common Shares

GlobeNewsWire • 12/15/23

AC Immune's Targeted Anti-pTau Active Immunotherapy for Alzheimer's Disease Advances into Phase 2b Trial

GlobeNewsWire • 12/15/23

Alzheimer's Disease Space Evolves in 2023: Stocks in Focus

Zacks Investment Research • 12/11/23

Is it a Good Idea to Invest in AC Immune (ACIU) Stock Now?

Zacks Investment Research • 12/05/23

AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO

GlobeNewsWire • 12/01/23

Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth

InvestorPlace • 11/29/23

Are Medical Stocks Lagging AC Immune (ACIU) This Year?

Zacks Investment Research • 11/09/23